GSK plc

04/24/2024 | Press release | Distributed by Public on 04/24/2024 00:06

US FDA accepts for priority review GSK’s application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced[...]